Ives Jeffrey L. - Insider Non-Derivative Transactions at Acumen Pharmaceuticals, Inc. (ABOS) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jun 4, 2025, Ives Jeffrey L.'s relationship to Acumen Pharmaceuticals, Inc. (ABOS) is Director, and currently has 12,800 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ABOS insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Ives Jeffrey L. - Insider Non-Derivative Transactions of ABOS Common Stock

Ives Jeffrey L. - Insider Non-Derivative Transactions at ABOS

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jun 5, 2025	Acquisition -- (Common Stock)	12800	0	12800
Aug 18, 2023	Sell -- (Common Stock)	39149	6.48	0
Aug 18, 2023	Sell -- (Common Stock)	2800	6.66	0
Aug 18, 2023	M -- (Common Stock)	2800	1.19	2800
Aug 18, 2023	M -- (Common Stock)	39149	0.72	39149